Assessment of cannabinoid induced gene changes: Tolerance and neuroprotection

Chemistry and Physics of Lipids

Volumn 121, Issue 1-2, 2002, Pages 257-266

  Grigorenko, Elena ^a   Kittler, Joseph ^b   Clayton, Chris ^c   Wallace, Don ^c   Zhuang, ShouYuan ^e   Bridges, Daniel ^d   Bundey, Sarah ^d   Boon, Andrew ^d   Pagget, Clair ^d   Hayashizaki, Seiji ^e   Lowe, Gavin ^d   Hampson, Robert ^e   Deadwyler, Sam ^e  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY OF BATH   (United Kingdom)

^e WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Cannabinoids; CDNA gene microarrays; In vivo and in vitro exposure; Neuroprotection; Tolerance

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID; CANNABINOID RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; MYELIN; PROTEIN KINASE C; PROTEIN SUBUNIT; PROTEOLIPID PROTEIN; REGULATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; DRUG EXPOSURE; DRUG TOLERANCE; GENETIC ENGINEERING; MEDICAL ASSESSMENT; MEMBRANE STRUCTURE; MUTATION; NERVE GROWTH; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC MEMBRANE; UPREGULATION;

ANIMALS; CANNABINOIDS; DNA, COMPLEMENTARY; DRUG TOLERANCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; HUMANS; NEUROPROTECTIVE AGENTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0037207075     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(02)00161-5     Document Type: Conference Paper

References (58)

1. 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain. Pharmacol. Biochem. Behav. 46:1993;575-579.
2. Aceto M.D., Scates S.M., Lowe J.A., Martin B.R. Dependence on delta-9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. J. Pharmacol. Exp. Ther. 278:1996;1290-1295.
3. Adams I.B., Martin B.R. Cannabis: pharmacology and toxicology in animals and humans. Addiction. 91:1996;1585-1614.
4. Ambrosini A., Bresciani L., Fracchia S., Brunello N., Racagni G. Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro. Mol. Pharm. 47:1995;1057-1064.
5. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orienius S., Lipton S., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
6. Aquino D.A., Peng D., Lopez C., Farooq M. The constitutive heat shock protein-70 is required for optimal expression of myelin basic protein during differentiation of oligodendrocytes. Neurochem. Res. 23:1998;413-420.
7. Becker C.G., Artola A., Gerardy-Schahn R., Becker T., Welzl H., Schachner M. The polysialic acid modification of the neural cell adhesion molecule is involved in spatial learning and hippocampal long-term potentiation. J. Neurosci. Res. 45:1996;143-152.
8. Blalock E., Chen K.C., Sharrow K., Herman J., Foster T., Landfield P.W. Hippocampal Gene Expression Profiling and Behavioral Deficits in Aging Rats: A Function/Expression Correlational Approach to Neuroinformatics. SN Abstr. 27:2001;780.12.
9. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospodin 1. J. Cell. Biol. 130:1995;503-506.
10. Breivogel C.S., Sim L.J., Childers S.R. Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J. Pharmacol. Exp. Ther. 282:1997;1632-1642.
11. 9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptor binding and activation of G-proteins in rat brain. J. Neurochem. 73:1999;2447-2459.
12. Carlezon W.A. Jr, Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., Nestler E.J. Regulation of cocaine reward by CREB. Science. 282:1998;2272-2275.
13. 9-tetrahydrocannabinol. J. Neurosci. 18:1998;5322-5332.
14. Chen Y., Buck J. Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism. J. Exp. Pharm. Therap. 293:2000;807-812.
15. Childers S.R., Deadwyler S.A. Role of cyclic AMP in the actions of cannabinoid receptors. Biochem. Pharmacol. 52:1996;819-827.
16. Choi D.W. Antagonizing excitoxicity: a therapeutic strategy for stroke. Mt. Sinai J. Med. 65:1998;133-138.
17. Choi D.W., Koh J.Y., Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci. 8:1988;185-196.
18. Crepel V., Congar P., Aniksztejn L., Gozlan H., Hammond C., Ben-Ari Y. Synaptic plasticity in ischemia: role of NMDA receptors. Prog. Brain Res. 116:1998;273-285.
19. Deadwyler S.A., Heyser C.J., Hampson R.E. Complete adaptation to the memory disruptive effects of delta-9-THC following 35 days of exposure. Neurosci. Res. Commun. 17:1995;9-18.
20. Di Marzo V., Deutsch D.G. Biochemistry of the endogenous ligands of cannabinoid receptors. Neurobiol. Dis. 5:1998;386-404.
21. Duggan D.J., Bittner M., Chen Y., Meltzer P., Trent J.M. Expression profiling using cDNA microarrays. Nat. Genet. 21:1999;10-14.
22. Eshar N., Stiem S., Kohen R., Tirosh O., Biegon A. Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist. Eur. J. Pharmacol. 283:1995;19-29.
23. 9-tetrahydrocannabinol, CP55940 and WIN55212. J. Pharmacol. Exp. Ther. 271:1994;1383-1390.
24. Felder C.C., Veluz J.S., Williams H.L., Briley E.M., Matsuda L.A. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol. 42:1992;838-845.
25. Grigorenko E. DNA Arrays. Technologies and Experimental Strategies. 2002;CRC Press, New York.
26. Grinstein G., Bret Jessee C., Hoffman P., O'Neil P., Gee A. High-dimensional visualization support for data mining gene expression data. DNA Arrays. Technologies and Experimental Strategies. 2002;75-113 CRC Press, New York.
27. 9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. Sci. USA. 95:1998;8268-8273.
28. Hampson R.E., Grigorenko E., Deadwyler S.A. Effects of acute and chronic cannabinoids on memory: from behavior to genes. Onaivi E.S. Biology of Marijuana: From Genes to Behavior. 2002;591-620 Taylor & Francis, New York.
29. Hartley D.M., Kurth M.C., Bjerkness L., Weiss J.H., Choi D.W. Glutamate receptor-induced 45Ca2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration. J. Neurosci. 13:1993;1993-2000.
30. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA. 87:1990;1932-1936.
31. Howlett A.C. The CB1 cannabinoid receptor in the brain. Neurobiol. Dis. 5:1998;405-416.
32. 9-tetrahydrocannabinol. Br. J. Pharmacol. 125:1998;1567-1577.
33. Kaminski N.E. Inhibition of the cAMP signaling cascade via cannabinoid receptors: a putative mechanism of immune modulation by cannabinoid compounds. Toxicol. Lett. 102:1998;59-63.
34. Kitagawa K., Matsumoto M., Tsujimoto Y., Ohtsuki T., Tanabe H., Mattinou J.C., Hori M., Yanagihara T. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of bcl-2 in transgenic mice. Stroke. 29:1998;2616-2621.
35. 9-THC in rats. Physiol. Genomics. 3:2000;175-185.
36. Lee J.M., Zipfel G.J., Choi D.W. The changing landscape of ischemic brain injury mechanisms. Nature. 399:1999;A7-A14.
37. Lin Y., Long J.B. Prolonged exposure to L-aminocyclopropanecarboxylic acid protects against subsequent glutamate toxicity in vitro. Eur. J. Pharm. 338:1997;289-292.
38. Mackie K., Devane W.A., Hille B. Anandamide an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44:1993;498-503.
39. Mailleux P., Verslype M., Preud'homme X., Vanderhaeghen J.J. Activation of multiple transcription factor genes by tetrahydrocannabinol in rat forebrain. Neuroreport. 5:1994;1265-1268.
40. Martin K.C., Kandel E.R. Cell adhesion molecules, CREB, and the formation of new synaptic connections. Neuron. 17:1996;567-570.
41. Mattson M.P. Apoptotic and anti-apoptotic synaptic signaling mechanisms. Brain Pathol. 10:2000;300-312.
42. Matsuda L., Lolait S.J., Browstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
43. McGregor I.S., Arnold J.C., Weber M.F., Topple A.N., Hunt G.E. A comparison of delta-9-THC and anandamide induced c-Fos expression in the rat forebrain. Brain Res. 802:1998;19-26.
44. Mechoulam R., Hanuš L. A historical overview of chemical research on cannabinoids. Chem. Phys. Lipids. 108:2000;1-13.
45. Nagayama T., Sinor A.D., Simon R.P., Chen J., Graham S.H., Jin K., Greenberg D.A. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J. Neurosci. 15:1999;2987-2995.
46. i and membrane currents during impaired mitochondrial metabolism in dissociated rat hippocampal neurons. J. Physiol. 507:1998;131-145.
47. Nye J.S., Voglmaier S., Martenson R.E., Snyder S.H. Myelin basic protein is an endogenous inhibitor of the high-affinity cannabinoid binding site in brain. J. Neurochem. 50:1988;1170-1178.
48. Panikashlli D., Simeonidou C., Ben-Shabat S., Hanus L., Breuer A., Mechoulam R., Shohmi E. An endogenous canabinoid (2-AG) is neuroprotective after brain injury. Nature. 413:2001;527-553.
49. Reynolds I.J., Hastings T.G. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 15:1995;3318-3327.
50. Shaywitz A.J., Greenberg M.E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Ann. Rev. Biochem. 68:1999;821-861.
51. Shen M., Thayer S.A. Cannabinoid receptor agonists protect cultures rat hippocampal neurons form excitotoxicity. Mol. Pharmacol. 54:1998;459-462.
52. 9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPS autoradiography in rat brain. J. Neurosci. 16:1996;8057-8066.
53. Skaper S.D., Buriani A., Toso R.D., Perelli L., Romanello S., Facci L., Leon A. The aliamide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc. Natl. Acad. Sci. 93:1996;3984-3989.
54. Southern E., Mir K., Schchepinov M. Molecular interactions on microarrays. Nat. Genet. (Suppl.). 21:1999;5-10.
55. Tremblay R., Chakravarthy B., Hewitt K., Tauskela J., Morley P., Atkinson T., Durkin J.P. Transient NMDA receptor inactivation provides long-term protection to cultured cortical neurons from a variety of death signals. J. Neurosci. 20:2000;7163-7192.
56. 9-THC on the expression of CB1 receptor mRNA in different rat brain regions. Mol. Brain Res. 62:1998;141-149.
57. Zhuang S.Y., Bridges D., Grigorenko E., Hampson R.E., Deadwyler S.A. Neurotoxicity and protection by cannabinoids. Soc. Neurosci. Abstr. 25:1999;1197.
58. Zhuang S.Y., Boon A., Hampson R.E., Deadwyler S.A. Pre-exposure to cannabinoids protects against NMDA receptor induced calcium influx in cultured hippocampal neurons. Soc. Neurosci. Abstr. 26:2000;2165.